• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.

作者信息

Lane Deirdre A, Lip Gregory Y H

出版信息

Stroke. 2008 Jan;39(1):7-9. doi: 10.1161/STROKEAHA.107.496554. Epub 2007 Nov 29.

DOI:10.1161/STROKEAHA.107.496554
PMID:18048849
Abstract
摘要

相似文献

1
Barriers to anticoagulation in patients with atrial fibrillation: changing physician-related factors.心房颤动患者抗凝治疗的障碍：不断变化的医生相关因素。
Stroke. 2008 Jan;39(1):7-9. doi: 10.1161/STROKEAHA.107.496554. Epub 2007 Nov 29.
2
Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.非瓣膜性心房颤动患者使用抗凝治疗的障碍：澳大利亚家庭医生的代表性调查
Stroke. 2008 Jan;39(1):227-30. doi: 10.1161/STROKEAHA.107.495036. Epub 2007 Nov 29.
3
Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.中国非瓣膜性心房颤动急性缺血性脑卒中患者出院时华法林的使用情况。
Stroke. 2016 Feb;47(2):464-70. doi: 10.1161/STROKEAHA.115.011833. Epub 2015 Dec 22.
4
Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.医生对非瓣膜性心房颤动患者使用华法林的获益与风险的认知。
CMAJ. 2001 Aug 7;165(3):301-2.
5
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study.房颤患者抗凝治疗中医护人员与患者观点的差异：观察性研究
BMJ. 2001 Nov 24;323(7323):1218-22. doi: 10.1136/bmj.323.7323.1218.
6
Clinical inquiries. Does combining aspirin and warfarin decrease the risk of stroke for patients with nonvalvular atrial fibrillation?临床问题。对于非瓣膜性心房颤动患者，联合使用阿司匹林和华法林是否能降低中风风险？
J Fam Pract. 2004 Jul;53(7):570-5.
7
Stroke in heart failure: atrial fibrillation revisited?心力衰竭中的中风：重新审视心房颤动？
J Stroke Cerebrovasc Dis. 2010 Jan;19(1):1-2. doi: 10.1016/j.jstrokecerebrovasdis.2009.09.002.
8
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
9
Stroke prevention in elderly patients with atrial fibrillation.老年房颤患者的卒中预防
Lancet. 2007 Aug 11;370(9586):460-1. doi: 10.1016/S0140-6736(07)61208-2.
10
[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].[心房颤动的抗栓治疗。新推荐及治疗选择的背景]
Lakartidningen. 2008;105(37):2478-80.

引用本文的文献

1
Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA-AF.临床风险表型对心房颤动管理和自然史的影响：GLORIA-AF 研究报告。
J Am Heart Assoc. 2023 Oct 17;12(20):e030565. doi: 10.1161/JAHA.123.030565. Epub 2023 Oct 10.
2
Integrated Care in Atrial Fibrillation: A Road Map to the Future.心房颤动的综合护理：通向未来的路线图。
Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007411. doi: 10.1161/CIRCOUTCOMES.120.007411. Epub 2021 Mar 5.
3
Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation.
在新诊断为心房颤动的 Medicare 受益人群中，口服抗凝药依从性的轨迹。
J Am Heart Assoc. 2019 Jun 18;8(12):e011427. doi: 10.1161/JAHA.118.011427. Epub 2019 Jun 13.
4
Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians.降低老年非瓣膜性心房颤动患者的中风风险：临床医生实用指南。
Clin Interv Aging. 2017 Jan 23;12:175-187. doi: 10.2147/CIA.S111216. eCollection 2017.
5
Impact of a Computerized Antithrombotic Risk Assessment Tool on the Prescription of Thromboprophylaxis in Atrial Fibrillation: Hospital Setting.计算机化抗血栓风险评估工具对心房颤动患者血栓预防处方的影响：医院环境
Clin Appl Thromb Hemost. 2018 Jan;24(1):85-92. doi: 10.1177/1076029616670031. Epub 2016 Sep 26.
6
Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.对提出的华法林处方用于心房颤动的既定障碍的影响：对加拿大医生的调查。
Thromb J. 2014 Jun 23;12:13. doi: 10.1186/1477-9560-12-13. eCollection 2014.
7
Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis.抗凝药物用于预防心房颤动患者中风：一项多支付方分析的结果
BMC Health Serv Res. 2014 Jul 28;14:329. doi: 10.1186/1472-6963-14-329.
8
Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation.在患有心房颤动的商业人群中使用抗凝剂预防中风。
Am Health Drug Benefits. 2012 Jul;5(5):291-8.
9
A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.一项关于国家患者安全目标前后口服抗凝治疗起始情况的非实验性研究。
BMJ Open. 2014 Feb 12;4(2):e003960. doi: 10.1136/bmjopen-2013-003960.